Metabolic gene polymorphism frequencies in control populations.Seymour Garte, Angela Risch, Laura Gaspari et al.|PubMed|2001Cited by 847
Type I and II Endometrial Cancers: Have They Different Risk Factors?Veronica Wendy Setiawan, Jennifer A. Doherty, Piet A. van den Brandt et al.|Journal of Clinical Oncology|2013Cited by 833
Approaching Health Disparities From a Population Perspective: The National Institutes of Health Centers for Population Health and Health DisparitiesRichard B. Warnecke, Robert A. Hiatt, April Oh et al.|American Journal of Public Health|2008Cited by 565
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study GroupTimothy R. Rebbeck, Barbara Weber, Tara M. Friebel et al.|Journal of Clinical Oncology|2005Cited by 406
Factors Determining Dissemination of Results and Uptake of Genetic Testing in Families with Known <i>BRCA1/2</i> MutationsEsmé Finlay, Susan M. Domchek, Jill E. Stopfer et al.|Genetic Testing|2008Cited by 168